Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Caris Life Sciences, Inc. - Common Stock (NQ:CAI)

30.41 +0.88 (+2.96%)
Delayed Quote Updated: 2:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Caris Life Sciences, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
X-ray Flat Panel Detector Market Size, Report Growth By 2035 ↗
The most recent research report on the "X-ray Flat Panel Detector Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic for 
Via Talk Markets
Topics Economy
News headline image
You’ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has – and He Likes What He Sees.
Caris Life Sciences just earned a $33.87 million vote of confidence from Stanley Druckenmiller, and most people completely missed it. 
Via Barchart.com
Topics Artificial Intelligence Initial Public Offering
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79% ↗
Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and biopharma partnerships as it looks to build on recent revenue growth following its... 
Via MarketBeat
Topics Initial Public Offering
Caris Life Sciences (NASDAQ:CAI) Slides 10% Despite Q1 Earnings Beat ↗
Via Chartmill
Caris Life Sciences Inc (NASDAQ:CAI) Earnings Report Triggers 14.7% Surge After Major EPS and Revenue Beat ↗
Via Chartmill
News headline image
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
From BioMedWire
Via GlobeNewswire
News headline image
Virtuoso Bass, Issue 4: “The Founding Four” Establishes the Canon of Jazz Fusion Bass
KL Publishing Group proudly announces the release of Virtuoso Bass, Issue 4: “The Founding Four,” a landmark edition devoted to documenting and canonizing the architects of jazz fusion bass while... 
Via PRUnderground
News headline image
Caris (CAI) Q1 2026 Earnings Call Transcript ↗
Caris (CAI) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
What’s Happening with Religious Orders? New Book Traces the Future of Consecrated Life
Via Get News
Topics Religion
News headline image
Debut Novel Little Mobile Home on the Tundra by T.D. Flenaugh Gives Voice to the Children Who Had to Raise Themselves
Via AB Newswire
News headline image
The Gatekeeper of the AI Era: A Comprehensive Deep Dive into ASML Holding N.V. (2026 Research Feature)
Today is April 15, 2026. Introduction In the global theater of technology, few companies hold as much leverage as ASML Holding N.V. (Nasdaq: ASML / Euronext Amsterdam: ASML). While names like Nvidia... 
Via Finterra
Topics Artificial Intelligence Economy Supply Chain
News headline image
The High-NA Era: A Deep Dive into ASML’s 2026 Monopoly and the Future of AI Silicon
Today’s date: April 15, 2026. Introduction In the global theater of technology and geopolitics, few companies carry as much weight as ASML Holding N.V. (NASDAQ: ASML, Euronext Amsterdam: ASML). Based... 
Via Finterra
Topics Artificial Intelligence Economy Supply Chain
News headline image
Debut Novel Little Mobile Home on the Tundra Gives Voice to the Children Who Had to Raise Themselves
Via AB Newswire
News headline image
New Book Maps the Canonical Path for Emerging Religious Communities
Via Get News
Topics Religion
News headline image
"Crooked Soldiers" Hits #1 New Release in Cultural, Ethnic & Regional Humor on Amazon
Via PRLog
News headline image
The Tech Stock With More Potential Than Any Cryptocurrency ↗
Bitcoin has potential, so do Ethereum, Monero, and all the others, but ASML has even more as the monopoly underpinning the whole tech industry. 
Via The Motley Fool
Topics Economy
News headline image
Pamela Waggoner Good’s Memoir He Never Let Go Wins International Impact Book Award for Transformative Stories
Via Get News
News headline image
2 Artificial Intelligence (AI) Stocks That Wall Street Loves but Most Investors Haven't Heard Of ↗
There's more to AI than just the big-name stocks in the industry. 
Via The Motley Fool
Topics Artificial Intelligence
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Sigma Announces Development of 85mm F1.2 DG | Art Lens for Full-Frame Mirrorless Cameras
Ronkonkoma, New York--(Newsfile Corp. - February 25, 2026) - Sigma Corporation of America, the US subsidiary of Sigma Corporation (CEO:... 
Via Newsfile
News headline image
Sigma Launches New Large-Aperture, Wide-Angle APS-C Lens: 15mm F1.4 DC | Contemporary
Ronkonkoma, New York--(Newsfile Corp. - February 24, 2026) - Sigma Corporation of America, the US subsidiary of Sigma Corporation (CEO:... 
Via Newsfile
News headline image
THE CHAPEL OF THE HOLY CHALICE HOSTS THE OFFICIAL PRESENTATION AND BLESSING OF THE PILGRIMAGE CREDENTIALS OF 'THE WAY OF THE HOLY GRAIL' …FOR THE FIRST DIOCESAN YOUTH PILGRIMAGE
February 20, 2026 -- The youth of Valencia take over the legacy of the Holy Chalice with a pilgrimage that unites faith, culture, and identity 
Via 24-7 Press Release
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
This UK-based biotech advances clinical-stage therapies for rare diseases, targeting specialty care markets with a diversified pipeline. 
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients with limited treatment options. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
BrightSpring Health Services delivers integrated pharmacy and clinical care to Medicare, Medicaid, and insured patients nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Canon Law Scholar Eileen Jaramillo Announces Forthcoming Guide on Discerning Charism in Emerging Religious Communities
Via Get News
Topics Religion
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.